New insights into the genetics of Alzheimer's disease

Annals of Medicine

Volumn 28, Issue 3, 1996, Pages 255-258

  Hardy, John ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Amyloid; Apolipoprotein E; APP; Genetics; Presenilin 1; Presenilin 2

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 19; GENE LOCUS; GENE MUTATION; HUMAN; MOLECULAR GENETICS; ONSET AGE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029945015     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899609033127     Document Type: Short Survey

References (38)

1. Hardy J, Duff K. Heterogeneity in Alzeimer's Disease. Ann Med 1993; 25: 437-40.
2. Suzuki N, Cheung TT, Xai XD, et al. An increased percentage of long amyloid beta-protein secreted by familial amyloid beta-protein precursor (APP717) mutants. Science 1994; 264: 1336-40.
3. Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem. 1994; 269: 17741-8.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
5. Sherrington R, Roagaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
6. Levy-Lahad E, Wasco W, Wijsman E, et al. Candidate locus for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 268: 973-7.
7. Poirier J, Hess M, May P, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesions. Mol Brain Res 1991; 11: 97-106.
8. Namba Y, Tomonaga M, Kawasaki H, Otono E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creuzfeldt-Jakob disease. Brain Res 1991; 541: 163-6.
9. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1993; 135: 235-9.
10. Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet 1987; 4: 97-108.
11. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 1977-81.
12. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with last onset Alzheimer's disease: population based study. BMJ 1994; 309: 636-8.
13. Houlden H, Crook R, Hardy J, Roques P, Collinge J, Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the ApoE locus. Neurosci Lett 1994; 174: 222-4.
14. Houlden H, Collinge J, Kennedy A, et al. ApoE genotype and Alzheimer's disease. Lancet 1993; 342: 737-8.
15. Van Broeckhoven C, Backhovens H, Cruts M, et al. ApoE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169: 179-80.
16. Royston MC, Mann D, Pickering-Brown S, et al. Apolipoprotein Eε2 allele promotes longevity and protects patients with Down's syndrome from the development of dementia. Neuroreport 1994; 5: 2583-95.
17. Chartier MC, Harlin MC, Parfitt M, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569-74.
18. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease. Lancet 1994; 343: 1432-3.
19. Maestre G, Ottamen R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genetic risk. Ann Neurol 1995; 37: 254-9.
20. van Duijn CM, Deknijff P, Cruts P, et al. Apolipoprotein E4 allele in a population-based study of early onset Alzheimer's disease. Nat Genet 1994; 7: 74-8.
21. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994; 7: 180-4.
22. Strittmatter WJ, Weisgraber KH, Huang D, et al. Binding of human apolipoprotein E to beta/A4 peptide: isoform-specific effects and implications for late onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098-102.
23. Roses AD. Apolipoprotein E affects the rate of Alzheimer's disease expression: beta-amyloid burden is a secondary consequence dependent on ApoE genotype and duration of disease. J Neuropathol Exp Neurol 1994; 5: 429-37.
24. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17: 529-30.
25. Slunt H, Thinakaran G, Lee M, Sisodia SS. Nucleotide sequence of the chromosome 14-encoded S182 cDNA and revised secondary structure prediction. Amyloid 1995; 2: 188-90.
26. Clark RF, Hutton M, Fuldner, et al. The structure of the Presenilin 1 (S182) gene and identification of six novel mutations in early onset Alzheimer's disease families. Nat Gene 1995; 11: 219-22.
27. Perez-Tur J, Froelich S, Prihar G, et al. Identification of a mutation in Alzheimer's disease which destroys a splice acceptor site in the presenilin-1 gene. Neuroreport 1995; 7: 204-7.
28. Wasco W, Pettingell WP, Jondro PD, et al. Familial Alzheimer's disease chromosome 14 mutations. Nat Med 1995; 11: 848.
29. Rogaev EI, Sherrington R, Rogaeva E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8.
30. Campion D, et al. Mutations of the presenilin 1 gene in families with early onset Alzheimer's disease. Hum Mol Genet 1995; 11: 2373-7.
31. Cruts M, Backhovens M, Wang SY, et al. Molecular genetic analysis of familial early onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet 1995; 4: 2363-71.
32. Hutton M, Busfield F, Wragg M, et al. Complete analysis of the presenilin 1 gene in families with early onset Alzheimer's disease. Neuroreport (in press).
33. Van Broeckhoven CM. The presenilins in Alzheimer's disease. Nat Genet 1995; 11: 230-2.
34. Levy-Lahad E, Wijsman E, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 268: 970-2.
35. Levitan D, Greenwald I. Facilitation of lin-12 mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377: 351-4.
36. Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1992; 119: 55-68.
37. Wang Q, Curran ME, Spawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1995; 12: 17-23.
38. Querfurth PH, Wijsman EM, St. George Hyslop P, et al. β APP mRNA is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Mol Brain Res 1995: 28; 319-37.